Detalhe da pesquisa
1.
Patient characteristics that predict Richter's transformation in patients with chronic lymphocytic leukemia treated with ibrutinib.
Am J Hematol
; 98(1): 56-65, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216791
2.
Leukemic B Cell CTLA-4 Suppresses Costimulation of T Cells.
J Immunol
; 202(9): 2806-2816, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910862
3.
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia.
Blood
; 127(9): 1117-27, 2016 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26813675
4.
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Blood
; 125(20): 3128-32, 2015 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25838351
5.
Toll-Like Receptors and Dectin-1, a C-Type Lectin Receptor, Trigger Divergent Functions in CNS Macrophages.
J Neurosci
; 35(27): 9966-76, 2015 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26156997
6.
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.
Blood
; 122(15): 2539-49, 2013 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23886836
7.
Tetraspanins as therapeutic targets in hematological malignancy: a concise review.
Front Physiol
; 6: 91, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25852576
8.
Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.
PLoS One
; 8(10): e76607, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130782